Skip to content
HeyJared

Sahil Pandey

Reporter · MY

Indexed articles, last 90 days
3
Latest publication
Sep 2, 2026
Outlet visibility, for Thestar
Top 5K sites
Earliest in this view
Jul 30, 2026

Latest articles

  1. Article · Sep 2, 2026 · Sahil Pandey

    Owkin signs AI drug discovery deal with Boehringer for cancer, immunology (opens the original)

    Excerpt · Positive tone · English

    Read excerpt

    Sept 2 (Reuters) - ⁠AI company Owkin said on Wednesday ⁠it has signed a licensing deal ‌with Germany's Boehringer Ingelheim, giving the drugmaker access to its AI research platform and patient data to speed ​up discovery of drugs for ⁠cancer and immunity-related ⁠diseases. The deal adds Boehringer to a growing list ⁠of ‌drugmakers using Owkin's AI technology, "K Pro". AstraZeneca licensed it in May, ⁠while Sanofi expanded its partnership with a ​five-year ‌agreement in June.

  2. Article · Aug 26, 2026 · Sahil Pandey

    Boston Scientific hit by cyberattack, global operations affected (opens the original)

    Excerpt · Critical tone · English

    Read excerpt

    Aug 26 (Reuters) - Boston ⁠Scientific said on Wednesday that a cybersecurity incident ⁠had disrupted global operations, including some information systems ‌used to process and ship customer orders. The medical device maker said it detected the incident on August 25 and had activated incident-response procedures, ​working with third-party cybersecurity specialists to ⁠investigate and contain the ⁠threat.

  3. Article · Jul 30, 2026 · By Sahil Pandey

    Labcorp raises annual profit forecast on strong testing demand (opens the original)

    Excerpt · Neutral tone · English

    Read excerpt

    July 30 (Reuters) - Laboratory operator Labcorp raised its annual profit forecast and posted better-than-expected second-quarter results on Thursday, ‌as steady demand for diagnostic testing and growth in ‌its drug-development services business boosted performance. Shares of the company fell about 6% in ​premarket trading. • The company's diagnostics business has benefited from specialty testing and laboratory management agreements, while improved pharmaceutical and biotechnology spending has su

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 5K sites

For Thestar, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Sahil Pandey